NPI registry status
Active
2026 NPPES data Addiction Medicine (Psychiatry & Neurology) Physician NPI 1215924030 M.D.
Verify on CMS → James McKnight, M.D.
Addiction Medicine (Psychiatry & Neurology) Physician in New York, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 648 in Addiction Medicine (Psychiatry & Neurology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 143 beneficiaries · Addiction Medicine (Psychiatry & Neurology) Physician avg: 1K
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$63.95
3 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
James McKnight, M.D. filed 2,983 Medicare Part D claims in 2024 as an Addiction Medicine (Psychiatry & Neurology) Physician in New York, New York, prescribing 97% generic.
- 3K
- Part D claims, 2024
- 97%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥88th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about James McKnight, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1215924030), first enumerated 10/06/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,983 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$63.95 in reported industry payments (3 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not James McKnight, M.D.'s individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1215924030 · Addiction Medicine (Psychiatry & Neurology) Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1215924030
- ENUM-LEGACY 2005
- TAX-NARROW 648
- RX-MID 2,983
- BOOK-THIN 60 in New York
- PHOTO-ENUM James Corcoran · 2005
James McKnight, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
2,983 ≥ 88th percentile 88% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
James McKnight, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about James McKnight, M.D.?
Quality data not reportedPrimary specialty
Addiction Medicine (Psychiatry & Neurology) Physician
Medicare Part D claims
2,983 187% vs specialty avg
Specialty distribution in New York
How Addiction Medicine (Psychiatry & Neurology) Physician compares to other specialties among New York providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Addiction Medicine (Psychiatry & Neurology) Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1215924030 |
|---|---|
| Specialty | Addiction Medicine (Psychiatry & Neurology) Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 10/06/2005 |
Hospital and facility affiliations
Facilities where James McKnight, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Metropolitan Center For Mental Health Inc
New York, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for James McKnight, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$64
Largest payer
Alkermes, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to James McKnight, M.D.. To verify James McKnight, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
James McKnight, M.D. - brand share 3.0%
Addiction Medicine (Psychiatry & Neurology) Physician average
3% brand-name claims vs 97% generic, on 2,983 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,983
Total Claims
$244K
Total Drug Cost
143
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 3,060.667
- Total Day Supply
- 91,248
- Brand vs Generic
- 3% brand / 97% generic
- Brand Drug Cost
- $213K
- Generic Drug Cost
- $31K
Patient Demographics
- Average Patient Age
- 62.2 years
- Avg HCC Risk Score
- 1.46
- Gender Split
- 74% female / 26% male
- Age Distribution
- <65: 61, 65-74: 63, 75-84: 19, 85+: 0
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What James McKnight, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Zolpidem Tartrate
Zolpidem Tartrate
241 claims
- Clonazepam
Clonazepam
206 claims
- Trazodone Hcl
Trazodone Hcl
201 claims
- Fluoxetine Hcl
Fluoxetine Hcl
141 claims
- Escitalopram Oxalate
Escitalopram Oxalate
129 claims
- Aripiprazole
Aripiprazole
122 claims
- Quetiapine Fumarate
Quetiapine Fumarate
109 claims
- Risperidone
Risperidone
107 claims
| Drug | Claims |
|---|---|
| Zolpidem Tartrate | 241 |
| Clonazepam | 206 |
| Trazodone Hcl | 201 |
| Fluoxetine Hcl | 141 |
| Escitalopram Oxalate | 129 |
| Aripiprazole | 122 |
| Quetiapine Fumarate | 109 |
| Risperidone | 107 |
| Citalopram Hbr Citalopram Hydrobromide | 94 |
| Sertraline Hcl | 87 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Addiction Medicine (Psychiatry & Neurology) Physician in NY →
All providers in New York →
Compare specialties →
Addiction Medicine (Psychiatry & Neurology) Physician Overview
How James McKnight, M.D. fits within the Addiction Medicine (Psychiatry & Neurology) Physician landscape nationally.
648
Addiction Medicine (Psychiatry & Neurology) Physician Providers in US
49
States with Addiction Medicine (Psychiatry & Neurology) Physician
1,039
Avg Claims per Provider
James McKnight, M.D.'s 2,983 claims are above the specialty average of 1,039.
Nationwide Addiction Medicine (Psychiatry & Neurology) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for McKnight, both outside New York so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Addiction Medicine (Psychiatry & Neurology) Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as McKnight.
One of 60 Addiction Medicine (Psychiatry & Neurology) Physician providers enrolled in New York, 5 are shown here.
Frequently Asked Questions
What is James McKnight, M.D.'s specialty? ▼
James McKnight, M.D. specializes in Addiction Medicine (Psychiatry & Neurology) Physician and practices in New York, New York. Credentials: M.D..
How much does James McKnight, M.D. prescribe under Medicare Part D? ▼
In 2024, James McKnight, M.D. wrote 2,983 Medicare Part D claims totaling $244K in drug costs for 143 beneficiaries.
Where is James McKnight, M.D. located? ▼
James McKnight, M.D. is located at 154 W 127TH ST, New York, NY, 10027. Phone: (404) 688-1350.
What is James McKnight, M.D.'s NPI number? ▼
James McKnight, M.D.'s National Provider Identifier (NPI) is 1215924030, issued on 10/06/2005.
Does James McKnight, M.D. prescribe more brand-name or generic drugs? ▼
James McKnight, M.D.'s prescribing is 3% brand-name and 97% generic drugs by claim count, with $213K in brand drug costs.
How many Addiction Medicine (Psychiatry & Neurology) Physician providers are there in the US? ▼
There are 648 Addiction Medicine (Psychiatry & Neurology) Physician providers across 49 states in the US. The average Addiction Medicine (Psychiatry & Neurology) Physician provider writes 1,039 Medicare Part D claims per year.
What drugs does James McKnight, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, James McKnight, M.D.'s most frequently prescribed drugs include Zolpidem Tartrate, Clonazepam, Trazodone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does James McKnight, M.D. accept Medicare? ▼
James McKnight, M.D. appears in CMS Medicare data with 2,983 Part D claims and 143 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify James McKnight, M.D.'s credentials? ▼
James McKnight, M.D.'s NPI is 1215924030 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.